2Seventy Bio Inc banner

2Seventy Bio Inc
NASDAQ:TSVT

Watchlist Manager
2Seventy Bio Inc Logo
2Seventy Bio Inc
NASDAQ:TSVT
Watchlist
Price: 5 USD Market Closed
Market Cap: $266.2m

Intrinsic Value

The intrinsic value for 2Seventy Bio Inc (TSVT) under the Base Case is 4.15 USD. Compared with the current market price of 5 USD, the stock appears Overvalued by 17%.

Based on two methods:

DCF suggests undervaluation, while multiples suggest overvaluation.

TSVT Intrinsic Value
4.15 USD
Overvaluation 17%
Intrinsic Value
Price $5
Worst Case
Base Case
Best Case
Get notified when the price drop
Track Buy Zone
20% below Intrinsic Value $3.32
Get notified when the price drops into your buy zone
Current Price $5
Intrinsic Value $4.15
Margin of Safety 20% $3.32
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about TSVT?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is TSVT valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for 2Seventy Bio Inc.

Explain Valuation
Alternatives to TSVT

Fundamental Analysis

Financials
Efficiency

Earnings Waterfall
2Seventy Bio Inc

Wall St
Price Targets

Dividends

2Seventy Bio Inc
does not pay dividends
Shareholder Yield

Competitive Landscape

Ownership

TSVT Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one TSVT stock?

The intrinsic value for 2Seventy Bio Inc (TSVT) under the Base Case is 4.15 USD.

Is TSVT stock undervalued or overvalued?

Compared with the current market price of 5 USD, the stock appears Overvalued by 17%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett